Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier

American Journal Of Pathology(2020)10.1016/j.ajpath.2020.06.004Source: DataRank Database

The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier is a research paper published in American Journal Of Pathology (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: hybridTopics (25)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Zhonghao Yan ORCID,Komal Chaudhry,Andrius Kazlauskas ORCID,Yueru Li ORCID

Live enrichment

PubMed:32590003 PMC:PMC7538812

NEI NIH HHS

Grant: R01 EY031350

NCATS NIH HHS

Grant: UL1 TR002003

National Institutes of Health

Grant: 5UL1TR002003-08

Clinical and Translational Science Award

Foundation for the National Institutes of Health

Juvenile Diabetes Research Foundation International

University of Illinois at Chicago

hybridLicense: Elsevier Non-Commercial

publisherhttps://api.elsevier.com/content/article/PII:S0002944020302959?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002944020302959?httpAccept=text/plain

https://doi.org/10.1016/j.ajpath.2020.06.004

http://ajp.amjpathol.org/article/S0002944020302959/pdf

https://pubmed.ncbi.nlm.nih.gov/32590003

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Retinal VesselsRetinaCells, CulturedEndothelial CellsHumansDiabetic RetinopathyVascular Endothelial Growth Factor AAngiotensin-Converting Enzyme InhibitorsCapillary PermeabilityRenin-Angiotensin SystemAngiotensin Receptor Antagonists

Keywords

Vascular Endothelial Growth Factor ADiabetic RetinopathyEndothelial CellsRetinal VesselsAngiotensin-Converting Enzyme InhibitorsRetinaCapillary PermeabilityRenin-Angiotensin SystemAngiotensin Receptor AntagonistsHumansCells, Cultured

Sustainable Development Goals

SDG 3: 3. Good health

The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier

FAIR Checklist

Authors (4)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)